In Vitro Characterization of a Novel Factor Xa Inhibitor, RPR 130737

By Chu V.   Brown K.   Colussi D.   Choi Y.-M.   Green D.   Pauls H.W.   Spada A.P.   Perrone M.H.   Leadley R.J.   Dunwiddie C.T.  

Thrombosis Research, Vol. 99, Iss. 1, 2000-07 ,pp. : 71-82

Elsevier

Access to resources Recommend Favorite

Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor

By Becker Richard  

Journal of Thrombosis and Thrombolysis, Vol. 32, Iss. 2, 2011-08 ,pp. : 183-187

Springer Publishing Company

Access to resources Recommend Favorite

Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor

By Wong Pancras  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 4, 2011-05 ,pp. : 478-492

Springer Publishing Company

Access to resources Recommend Favorite

Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor

By Hara T.   Yokoyama A.   Morishima Y.   Kunitada S.  

Thrombosis Research, Vol. 80, Iss. 1, 1995-10 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

Vascular Endothelial Tissue Factor Pathway Inhibitor Kinetics in Culture Following Exposure to DX-9065a—A Selective and Direct Factor Xa Inhibitor

By Becker Richard   Alexander John   Li YouFu   Robertson Thomas   Kunitada Satoshi   Spencer Frederick   Yang Hongqiu   Harrington Robert  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 3, 2004-12 ,pp. : 193-197

Springer Publishing Company

Access to resources Recommend Favorite